Skip to content
MedsAcross

Medicine

Desmopressin 0.2 mg tablet

Desmopressin · Oral
Available on requestPrescription onlyUS FDAGeneric name

Desmopressin 0.2 mg tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Desmopressin
Brand
Sold under the generic name
Strength
0.2 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 1 bottle and 8 more
Manufacturers
Avet PharmaceuticalsIndiaAurobindo PharmaIndiaBryant Ranch PrepackAmerican Health PackagingApotexBluePoint LaboratoriesKVK-TechNordic PharmaNorthwind Health
Origin register
US FDA, United States
Storage
Store 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
H01BA02 Desmopressin
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
7 March 2006
Identifiers
RxCUI 833008, 849515DailyMed set ID 72aeef35-c102-b628-0219-9822651887eb, 0d447b48-3f4b-430e-9e68-d8b9401c002e, 24866ad0-94db-46a2-96c0-b362acd0271a +7NDC 60505-0258, 60687-732, 59651-250 +7Application ANDA077414, ANDA213095, ANDA210371 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle59651-250-01Aurobindo PharmaIndia21 March 2024
100 tablet in 1 bottle23155-490-01Avet PharmaceuticalsIndia26 May 2017
500 tablet in 1 bottle23155-490-05Avet PharmaceuticalsIndia26 May 2017
100 tablet in 1 bottle60505-0258-1Apotex7 March 2006
100 tablet in 1 bottle10702-170-01Kvk-Tech28 January 2019
1 bottle in 1 carton / 100 tablet in 1 bottle69918-201-01Nordic Pharma10 December 2015
90 tablet in 1 bottle63629-3257-1Bryant Ranch Prepack10 October 2024
90 tablet in 1 bottle71335-2342-1Bryant Ranch Prepack6 February 2024
30 blister pack in 1 carton / 1 tablet in 1 blister pack60687-732-21American Health Packaging28 December 2023
100 tablet in 1 bottle68001-575-00BluePoint Laboratories3 August 2023
30 tablet in 1 bottle, plastic51655-461-52Northwind Health29 October 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 February 1978Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Desmopressin 0.2 mg tablet.

Compare 1

Other strengths and forms of Desmopressin

Clinical summary

Desmopressin is a factor VIII activator indicated for the treatment of nephrogenic diabetes insipidus, among other approved uses. It is available as injection, tablets and nasal solution for intravenous, subcutaneous and oral use. MedsAcross supplies Desmopressin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Desmopressin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Desmopressin 0.2 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.